Barbara Unger

Welcome to Pharmaceutical Online’s Top 10 newsletter, our annual recap of the most popular guest columns, white papers, case studies, application notes, and products/services of the year. And what a year it has been! Unsurprisingly, regulatory matters make a few appearances in the newsletter. Other critical issues — manufacturing, quality, supply chain, and otherwise — maintain interest while the industry continues to develop and produce critical medicines for patients in need.

Application Note | Cytiva This application note provides recommendations from the execution of a closed and connected monoclonal antibody (mAb) process from design considerations to scale-up, including the small-scale modeling that directed the process at manufacturing scale.

Outsourced Pharma has a record of presenting readers with aspects of quality and risk management in drug development and manufacturing outsourcing.* Let’s add a basic introduction of a concept within quality risk management – Uncertainty – specifically for emerging biopharma organizations less attuned to the intricacies of quality-related deliberations.